Genome British Columbia
15
1M
13
0.65
1
0.13
1
- Areas of investment
Summary
Genome British Columbia is the famous Corporate Investor, which was founded in 2000. The leading representative office of defined Corporate Investor is situated in the Vancouver. The venture was found in North America in Canada.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Genome British Columbia, startups are often financed by Western Innovation (WINN) Initiative, Tom Williams, Rising Tide. The meaningful sponsors for the fund in investment in the same round are Tower Beach Capital, Quimby Investments, Coleco Investments. In the next rounds fund is usually obtained by Western Innovation (WINN) Initiative.
The important activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this Corporate Investor is 80 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars.
We can highlight the next thriving fund investment areas, such as Health Care, 3D Printing. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Aspect Biosystems, Acuva Technologies, LightIntegra Technology, Inc.. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Canada.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.65
- Follow on index
- 0.13
- Investments by industry
- Health Care (12)
- Biotechnology (8)
- Medical Device (4)
- Consumer Electronics (2)
- Medical (2) Show 14 more
- Investments by region
-
- Canada (15)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 9M
- Group Appearance index
- 0.33
- Avg. company exit year
- 5
- Avg. multiplicator
- 10.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Arbutus Medical | 13 Feb 2023 | Health Care, Medical Device, Hardware | Seed | 2M | British Columbia, Vancouver, Canada |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.